Medicine and Dentistry
Adverse Event
9%
Apoplexy
9%
Biochemical Recurrence
9%
Brachytherapy
9%
Combination Therapy
45%
Contraindication
27%
Evaluation Study
9%
Follow up
9%
Gland
9%
Gonadotropin
9%
Growth
9%
Hypophysis Apoplexy
9%
Injection
18%
Inpatient
18%
Leuprorelin
100%
Macroadenoma
9%
Magnetic Resonance Imaging
9%
Microadenoma
18%
Patient
54%
Pituitary Adenoma
18%
Pituitary Tumour
36%
Prostate Cancer
36%
Radiation Therapy
18%
Surgery
18%
Symptom
9%
INIS
adenomas
9%
brachytherapy
9%
cancer
36%
evaluation
9%
glands
9%
gonadotropins
9%
growth
9%
injection
18%
management
9%
nmr imaging
9%
patients
72%
prostate
45%
radiotherapy
18%
recovery
9%
surgery
9%
symptoms
9%
therapy
45%
tumors
36%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
9%
Biochemical Recurrence
9%
Cerebrovascular Accident
9%
Gonadotropin
9%
Hypophysis Adenoma
18%
Hypophysis Apoplexy
9%
Hypophysis Tumor
36%
Leuprorelin
100%
Macroadenoma
9%
Microadenoma
18%
Prostate Cancer
36%
Symptom
9%